PROSTATE CANCER SCREENING WITHIN A PROSTATE SPECIFIC ANTIGEN RANGE OF 3 TO 3.9 NG./ML.:
- 1 October 2001
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Urology
- p. 1339-1342
- https://doi.org/10.1097/00005392-200110000-00025
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- PROSTATE CANCER DETECTION AT LOW PROSTATE SPECIFIC ANTIGENJournal of Urology, 2000
- Changing role of 3 screening modalities in the European randomized study of screening for prostate cancer (Rotterdam)International Journal of Cancer, 1999
- Use of percentage of free prostate-specific antigen to identify men at high risk of prostate cancer when psa levels are 2.51 to 4 ng/mL and digital rectal examination is not suspicious for prostate cancer: an alternative modelUrology, 1999
- DIGITAL RECTAL EXAMINATION FOR DETECTING PROSTATE CANCER AT PROSTATE SPECIFIC ANTIGEN LEVELS OF 4 NG./ML. OR LESSJournal of Urology, 1999
- European randomized study of prostate cancer screening: first-year results of the Finnish trialBritish Journal of Cancer, 1999
- Evaluation of the Digital Rectal Examination as a Screening Test for Prostate CancerJNCI Journal of the National Cancer Institute, 1998
- CHARACTERISTICS OF SCREENING DETECTED PROSTATE CANCER IN MEN 50 TO 66 YEARS OLD WITH 3 TO 4 NG./ML. PROSTATE SPECIFIC ANTIGENJournal of Urology, 1998
- Prostate Cancer Detection in Men With Serum PSA Concentrations of 2.6 to 4.0 ng/mL and Benign Prostate ExaminationJAMA, 1997
- Serum Prostate Specific Antigen as Pre-Screening Test for Prostate CancerJournal of Urology, 1992
- Histologic grading of prostate cancer: A perspectiveHuman Pathology, 1992